Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – warrants of series TO7
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
Menu
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – warrants of series TO7
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Investor letters
2024
Investor letter September 30 2024
2023
Investor letter October 2
Investor letter July 28
Investor letter July 25
Investor letter July 19 (in Swedish)
2022 (only in Swedish)
Viktiga nyanställningar säkerställer fortsatt utvecklingsarbete av Psyros POC-plattform
Två bolag blir en koncern, med unika, patentsökta tekniker och oerhört kompetent personal
Välmeriterat och kompetent team stärker Prolight Diagnostics ytterligare
